Assessing compound carcinogenicity in vitro using connectivity mapping

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 201-207

  Caiment, Florian ^a   Tsamou, Maria ^a   Jennen, Danyel ^a   Kleinjans, Jos ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; 2,4 DINITROPHENOL; ACETAMIDE; AFLATOXIN; AMPHOTERICIN B; AZATHIOPRINE; BUTHIONINE SULFOXIMINE; CARBAMAZEPINE; CARBON TETRACHLORIDE; CARCINOGEN; CIMETIDINE; COUMARIN; CYCLOSPORIN A; DICLOFENAC; DOXORUBICIN; ETHINYLESTRADIOL; GLIBENCLAMIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHAPYRILENE; METHYLNITROSOUREA; METHYLTESTOSTERONE; NITROFURANTOIN; NITROSOMORPHOLINE; OMEPRAZOLE; PROPRANOLOL; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA1; TRIAZOLAM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL; CARCINOGEN TESTING; CONNECTIVITY MAPPING METHOD; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL; PREDICTION; PRIORITY JOURNAL; TRANSCRIPTOMICS;

CARCINOGENICITY TESTS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; REPRODUCIBILITY OF RESULTS; TOXICOGENETICS;

EID: 84891352904     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt278     Document Type: Article

References (28)

1. Hartung,T. (2009) Toxicology for the twenty-first century. Nature, 460, 208-212.
2. Ward,J.M. (2008) Value of rodent carcinogenesis bioassays. Toxicol. Appl. Pharmacol., 226, 212.
3. Knight,A. et al. (2005) Which drugs cause cancer? For. BMJ, 331, E389-E391.
4. Knight,A. et al. (2006) Animal carcinogenicity studies: implications for the REACH system. Altern. Lab. Anim., 34 (suppl. 1), 139-147.
5. Braga,R.C. et al. (2012) QSAR and QM/MM approaches applied to drug metabolism prediction. Mini Rev. Med. Chem., 12, 573-582.
6. Hennes,E.C. (2012) An overview of values for the threshold of toxicological concern. Toxicol. Lett., 211, 296-303.
7. van Delft,J.H. et al. (2004) Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. Carcinogenesis, 25, 1265-1276.
8. van Delft,J.H. et al. (2005) Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. Mutat. Res., 575, 17-33.
9. Ellinger-Ziegelbauer,H. et al. (2009) Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity. Toxicol. Lett., 186, 36-44.
10. Hu,T. et al. (2004) Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins. Mutat. Res., 549, 5-27.
11. Le Fevre,A.C. et al. (2007) Characterization of DNA reactive and non- DNA reactive anticancer drugs by gene expression profiling. Mutat. Res., 619, 16-29.
12. Li,H.H. et al. (2007) Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals. Mutat. Res., 623, 98-108.
13. Mathijs,K. et al. (2010) Gene expression profiling in primary mouse hepatocytes discriminates true from false-positive genotoxic compounds. Mutagenesis, 25, 561-568.
14. Tsujimura,K. et al. (2006) Prediction of carcinogenic potential by a toxicogenomic approach using rat hepatoma cells. Cancer Sci., 97, 1002-1010.
15. Magkoufopoulou,C. et al. (2012) A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis, 33, 1421-1429.
16. Lamb,J. et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 313, 1929-1935.
17. Qu,X.A. et al. (2012) Applications of Connectivity Map in drug discovery and development. Drug Discov. Today, 17, 1289-1298.
18. Farazi,P.A. et al. (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer, 6, 674-687.
19. Marioni,J.C. et al. (2008) RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res., 18, 1509-1517.
20. Yu,Y. et al. (2010) A comparative analysis of liver transcriptome suggests divergent liver function among human, mouse and rat. Genomics, 96, 281-289.
21. Tzur,G. et al. (2009) Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development. PLoS One, 4, e7511.
22. Uehara,T. et al. (2011) Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database. Toxicol. Appl. Pharmacol., 255, 297-306.
23. Zhang,S.D. et al. (2009) sscMap: an extensible Java application for connecting small-molecule drugs using gene-expression signatures. BMC Bioinformatics, 10, 236.
24. Hsu,C.N. et al. (2007) Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online). BMC Bioinformatics, 8, 66.
25. Capurro,M. et al. (2003) Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology, 125, 89-97.
26. Acevedo,L.G. et al. (2008) Analysis of the mechanisms mediating tumorspecific changes in gene expression in human liver tumors. Cancer Res., 68, 2641-2651.
27. Diamandis,E.P. (2010) Cancer biomarkers: can we turn recent failures into success? J. Natl Cancer Inst., 102, 1462-1467.
28. Ransohoff,D.F. (2005) Bias as a threat to the validity of cancer molecularmarker research. Nat. Rev. Cancer, 5, 142-149.